Cardarine is not a SARM. Despite being sold alongside SARMs on supplement websites and frequently grouped with them in bodybuilding forums, cardarine (also known as GW501516 or endurobol) works through a completely different biological mechanism. It belongs to a separate class of compounds called PPAR-delta agonists, which affect metabolism and energy use rather than hormones.
Why Cardarine Gets Mislabeled as a SARM
The confusion exists because cardarine is marketed and sold through the same channels as actual SARMs. The National Institutes of Health specifically notes that cardarine is among “several commercial products advertised as effective in increasing muscle growth for bodybuilding that are sometimes mistakenly claimed to be SARMs.” It shows up in the same online stores, the same capsule bottles, and the same discussion threads, so people naturally assume it’s the same type of compound. It isn’t.
How SARMs Actually Work
SARMs, or selective androgen receptor modulators, are synthetic drugs that bind to androgen receptors in your body. These are the same receptors that testosterone and other androgens activate. What makes SARMs “selective” is that they preferentially activate those receptors in muscle and bone tissue while producing fewer hormonal side effects on the prostate, skin, hair, and liver compared to traditional anabolic steroids. The selectivity comes not from differences in the receptor itself, but from variation in regulatory proteins across different tissues that modulate how the receptor responds.
In short, SARMs are hormonal compounds. They interact with the same system as testosterone, just in a more targeted way.
How Cardarine Works Instead
Cardarine operates on an entirely different pathway. It activates a nuclear receptor called PPAR-delta, which plays a central role in how your body processes energy. PPAR-delta is involved in reprogramming muscle fibers, building new mitochondria (the energy-producing structures inside cells), and regulating fat burning. It has nothing to do with androgen receptors or hormonal signaling.
The practical effect in animal studies is a shift in fuel source. Animals given GW501516 burned proportionally more fat and fewer carbohydrates during physical activity, which translated to improved running endurance. This was confirmed by measuring the ratio of carbon dioxide produced to oxygen consumed, a standard indicator of whether the body is burning fat or sugar. The compound essentially told muscles to prefer fat as fuel.
This is why cardarine is sometimes called a “metabolic modulator” or “endurance enhancer” rather than a muscle-building compound. Its primary effect is on energy metabolism, not on muscle growth through hormonal pathways.
A Quick Comparison
- SARMs: Bind androgen receptors. Promote muscle and bone growth through hormonal pathways. Can suppress natural testosterone production.
- Cardarine: Activates PPAR-delta receptors. Shifts energy metabolism toward fat burning. Does not interact with the hormonal system.
Because cardarine doesn’t touch the androgen receptor system, it doesn’t cause the hormonal suppression that actual SARMs can. You won’t see testosterone levels drop from cardarine use, nor would post-cycle therapy be relevant in the way it is for SARMs or steroids. The two compounds address fundamentally different systems in the body.
Regulatory Status
Cardarine was originally developed as a potential treatment for obesity, cardiovascular disease, and cancer. However, the pharmaceutical company that created it abandoned the project after preclinical safety testing revealed serious problems. In animal studies, doses of 10 to 100 mg/kg/day given to rats and mice over two years caused tumors throughout the body. Lower doses caused rectal bleeding in mice within six weeks, and moderate doses led to placental abnormalities in pregnant rats.
The drug never completed clinical trials and never received approval for human use. The World Anti-Doping Agency issued a rare public alert about GW501516, stating bluntly that “clinical approval has not, and will not be given for this substance.” WADA prohibits it under the category of metabolic modulators, not under the hormone or SARM category, which further reflects its distinct classification. Sport Integrity Australia confirmed that all clinical trials have been abandoned due to safety concerns.
Why the Distinction Matters
Understanding that cardarine is not a SARM isn’t just a technicality. It changes what you should expect the compound to do, what risks it carries, and how it interacts with your body. Someone researching SARMs for muscle-building purposes is looking at a hormonal intervention with one set of trade-offs: potential testosterone suppression, possible liver strain, and tissue-selective anabolic effects. Cardarine presents a completely different risk profile centered on metabolic changes and, based on animal data, serious cancer concerns at sustained doses.
The fact that these compounds share shelf space online doesn’t make them pharmacologically related. Ibutamoren (MK-677), another compound commonly sold as a SARM, is also misclassified. It’s actually a growth hormone secretagogue. Of five popular “SARMs” analyzed in one review, only three were actually SARMs at all. The supplement industry’s labeling practices don’t reflect what these compounds are or how they work.